Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

por de Vries, Elisabeth G. E., Rüschoff, Josef, Lolkema, Martijn, Tabernero, Josep, Gianni, Luca, Voest, Emile, de Groot, Derk Jan A., Castellano, Daniel, Erb, Gilles, Naab, Julia, Donica, Margarita, Deurloo, Regula, van der Heijden, Michiel S., Viale, Giuseppe
Publicado 2023

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

por Harbeck, Nadia, von Schumann, Raquel, Kates, Ronald Ernest, Braun, Michael, Kuemmel, Sherko, Schumacher, Claudia, Potenberg, Jochem, Malter, Wolfram, Augustin, Doris, Aktas, Bahriye, Forstbauer, Helmut, Tio, Joke, Grischke, Eva-Maria, Biehl, Claudia, Liedtke, Cornelia, De Haas, Sanne Lysbet, Deurloo, Regula, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Gluz, Oleg
Publicado 2021